arrow
G

Giada Sebastiani

mcgill university health centre
H指数:49
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An international multicenter study of MASLD prevalence among children and adolescents assessed by VCTE

国际多中心研究:通过VCTE评估儿童和青少年MASLD患病率

2026-10-120
OAAI
Delphi survey to explore core curriculum for training the next generation of hepatologists

德尔菲调查探索下一代肝病学家培训的核心课程

2026-08-010
PRE
Reply to “Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitis – Circular definition of CVRM comorbidities undermines the validity of core subgroup comparisons”

回复:“代谢功能障碍相关脂肪性肝炎患者的真实世界生活质量及医疗资源利用情况——心血管代谢风险因素管理合并症的循环定义削弱了核心亚组比较的有效性”

2026-07-270
OAAI
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease

脂肪性肝病的纤维化诊断创新和护理模式以改善纤维化检测和风险分层

2026-05-250
OAAI
Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to Azathioprine

系统性红斑狼疮妇女暴露于硫唑嘌呤后妊娠期肝内胆汁淤积症风险增加

2026-05-040
OA
Distinct Gut Microbiota Signatures Are Associated with Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease in People with HIV

HIV感染者中,独特的肠道微生物群特征与代谢功能障碍相关脂肪性肝病的严重程度相关。

2026-03-030
OAAI
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV

代谢功能障碍相关脂肪性肝病与人类免疫缺陷病毒感染者健康相关生活质量受损有关

2026-01-010
OAAI
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis

代谢功能障碍相关脂肪性肝炎治疗评估的替代终点专家德尔菲共识

2025-12-060
PRE
Prospective Comparison of DWI-Derived Virtual MR Elastography and Conventional MR Elastography in Metabolic Dysfunction-Associated Steatotic Liver Disease and Healthy Volunteers

前瞻性比较DWI衍生的虚拟磁共振弹性成像与常规磁共振弹性成像在代谢功能障碍相关脂肪性肝病和健康志愿者中的差异

2025-11-011
OAAI
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Younossi, Z.M.; de Avila, L.; Petta, S.; Hagström, H.; Kim, S.U.; Nakajima, A.; Crespo, J.; Castera, L.; Alkhouri, N.; Zheng, M.H.; 等. MASLD的纤维化、临床事件及死亡率的预测因素:全球MASLD研究的数据. 肝病学 2025. [Google Scholar] [CrossRef]

2025-11-013
PRE
EUS-GUIDED LIVER BIOPSY AND PORTAL PRESSURE MEASUREMENT COMPARED TO TRANSJUGULAR APPROACH: A RANDOMIZED CONTROLLED TRIAL

EUS引导下肝活检与门脉压力测量与经颈静脉入路比较:一项随机对照试验

2025-10-030
PRE
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021

可归因于代谢风险的原发性肝癌的全球,区域和国家负担: 对1990-2021全球疾病负担研究的分析

2025-10-017
PRE
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study

非侵入性试验在MASLD中的全球表现:G-MASLD研究的见解

2025-10-010
PRE